When is Hello Patient the better choice?

More autonomous across the full front office loop, inbound and outbound, with practices reported moving from 20 to 30 percent unanswered calls to zero, if maximal call coverage is the immediate goal. Candid about its stack and quick to deploy: it states it fine tunes existing models rather than claiming its own, names its voice partner, and publishes SOC 2 Type 2 and HIPAA directly. Broad across outpatient specialties including smaller settings that premium enterprise platforms tend not to prioritize.

When is Hyro the better choice?

The clearest architecture in the lane and the transparency a large system's review needs: a documented hybrid of LLMs, a conversational engine, small healthcare tuned models, and knowledge graphs that constrain what the agent can assert. Enterprise proven: 45 to 50 US health systems, more than 30 million patients, named clients including Intermountain and Baptist, Bon Secours invested as a client, and a 2026 Fierce 15 selection, against a competitor founded in 2024. Completes the transaction through direct API into Epic and CRMs rather than routing it, the capability that separates this tier from IVR replacement.

Head-to-Head

Hello Patient vs Hyro

Last VerifiedJuly 22, 2026

Verdict

If your failure mode is choosing the newest and most autonomous agent for an enterprise rollout without the track record or architectural visibility a large system needs, this pair frames the tradeoff. Hyro has built for healthcare since 2018 and offers the clearest architecture in the lane, a hybrid of large language models, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, deployed across 45 to 50 health systems with an investing client and direct API into Epic that completes tasks rather than routing them. Hello Patient, founded in 2024, is the more autonomous and faster to stand up, targeting a 100 percent answer rate across the front office, but with roughly a year of reported volume and no published escalation threshold. Enterprise depth and interrogable architecture, or a newer, more autonomous, quicker build.

Select Hello Patient if

More autonomous across the full front office loop, inbound and outbound, with practices reported moving from 20 to 30 percent unanswered calls to zero, if maximal call coverage is the immediate goal.
Candid about its stack and quick to deploy: it states it fine tunes existing models rather than claiming its own, names its voice partner, and publishes SOC 2 Type 2 and HIPAA directly.
Broad across outpatient specialties including smaller settings that premium enterprise platforms tend not to prioritize.

Select Hyro if

The clearest architecture in the lane and the transparency a large system's review needs: a documented hybrid of LLMs, a conversational engine, small healthcare tuned models, and knowledge graphs that constrain what the agent can assert.
Enterprise proven: 45 to 50 US health systems, more than 30 million patients, named clients including Intermountain and Baptist, Bon Secours invested as a client, and a 2026 Fierce 15 selection, against a competitor founded in 2024.
Completes the transaction through direct API into Epic and CRMs rather than routing it, the capability that separates this tier from IVR replacement.

Attribute Matrix

Side-by-Side

Axis	H Hello Patient	H Hyro
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship		—
HIPAA and BAA Posture		—
Security Certifications and Trust Center		—
FDA and Regulatory Status		—
AI Governance and Bias Disclosure		—
EHR and Interoperability Depth
Deployment Model and Data Residency		—
Commercial Transparency
Setting and Specialty Coverage		—

Disclosure

Both are vendor reported on their operational headlines and both leave the escalation trigger unpublished, the boundary that matters most for refill and triage adjacent requests; Hello Patient is graded a step lower on oversight, at C, for pairing a 100 percent answer target with no disclosed human handoff, while Hyro discloses that transfer exists but not when it fires. Hello Patient, founded in 2024, has no longitudinal track record; Hyro's adoption is independently corroborated. Neither publishes pricing, and Hyro is explicitly premium tier, with smaller practices often served by more accessible alternatives, a group Hello Patient targets. Hello Patient carries graded SOC 2 Type 2 and HIPAA in this index; Hyro's record does not, so confirm directly. Voice accuracy varies across accent and dialect.